Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapy
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/4/suppl_4/S35/6679015/4-suppl_4-S35.pdf
Reference16 articles.
1. Chemotherapy of gynaecologic cancer;Thigpen,1992
2. A randomized comparison of melphalan versus melphalan plus hexamethylmela-mine versus adriamycin plus cyclophosphamide in ovarian carcinoma;Omura;Cancer,1983
3. Therapy of stage III (optimal) epithelial carcinoma of the ovary with melphalan or melphalan plus corynebacterium parvum (a Gynaecologic Oncology Group study);Gall;Gynecol Oncol,1986
4. Second-look laparotomy in the patient with minimal residual stage III ovarian cancer (a Gynaecologic Oncology Group study);Creasman;Gynecol Oncol,1989
5. Long-term survival with advanced ovarian cancer: An analysis of 5-year survivors in the Australian trial comparing combination versus sequential chlorambucil and cisplatin therapy;Tattersall;Gynecol Oncol,1992
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In Vitro and In Silico Analysis of the Anticancer Effects of Eurycomanone and Eurycomalactone from Eurycoma longifolia;Plants;2023-07-31
2. Efficacy of cisplatin combined with vinorelbine as second- or higher-line palliative chemotherapy in patients with advanced ovarian cancer;Medicine;2023-03-17
3. What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer;Gynecologic Oncology;2022-09
4. Retracted: Quercetin induces endoplasmic reticulum stress to enhance c DDP cytotoxicity in ovarian cancer: involvement of STAT 3 signaling;The FEBS Journal;2015-02-11
5. Ovarian cancer vaccine trials and tribulations;Expert Opinion on Biological Therapy;2006-12-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3